Media center

At PATH, our global health experts are developing partnerships, new devices, and solutions to the world's most pressing health needs. Contact us to speak with one of PATH's experts today.

Contact Us

Director of Global Strategic Communications:
Julianna Longo

Phone: 206.285.3500

Fax: 206.285.6619

Email: media@path.org

Recent Press Coverage

  1. The Milken Institute School of Public Health at George Washington University announced a partnership with PATH, funded by the Bill & Melinda Gates Foundation, to enhance immunization in countries with conflict
    Published: April 2024
  2. An article announcing the Gates Foundation’s refreshed open access and preprint policy highlights the experience of PATH’s Emmanuel Mugisha, who says researchers in low- and middle-income countries face daily barriers as a result of journal paywalls
    Published: March 2024
  3. The Men5CV (MenFive) pentavalent meningitis vaccine—the result of a 13-year development collaboration between Serum Institute of India and PATH—could help eliminate a leading cause of neurological disease and disability in sub-Saharan Africa.
    Published: March 2024
  4. The New York Times remembers Kent Campbell, the creator and first director of PATH’s Malaria Control and Elimination Partnership in Africa (MACEPA) program. Dr. Campbell is remembered for a legacy of lifesaving work over four decades in public health.
    Published: March 2024

We develop evidence-based expertise and resources

Our global team leverages data and evidence to develop resources and innovations that bring good health to more people.

Explore our evidence

Join the latest discussions on health equity.

We partner with the public and private sector, government, and academia from around the world to share insightful conversations on the latest topics affecting health equity.

Explore PATH events

PATH Newsroom

957 Item s
957 Item s
    Date
    From
    To
  1. Published: August 2021
    Statement
  2. Published: August 2021
    Statement
  3. The Partnership for Vivax Elimination (PAVE) will support endemic countries in achieving their Plasmodium vivax (P. vivax) malaria elimination goals.PAVE will advance the development of quality-assured, child-friendly treatments for relapse prevention, and generate and consolidate evidence to support malaria-endemic countries in developing and implementing new strategies to eliminate P. vivax malaria.
    Published: July 2021
    Press Release
  4. Effective and affordable new research diagnostic tool can measure up to 11 key biomarkers of environmental enteric dysfunction with a single test
    Published: July 2021
    Press Release
  5. Published: July 2021
    Press Release